Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
339 entries « 2 of 34 »

Gao Z, Robinson K, Skowronski DM, De Serres G, Withers SG

Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent.

Journal Article

Vaccine, 38 (4), pp. 715-718, 2020, ISSN: 0264-410X.

Abstract | Links:

Brousseau N, Skowronski DM, Bellemare D, Amini R, Joffres Y, Clarke Q, Quach C, Rallu F, Hoang L, De Serres G

Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.

Journal Article

Vaccine, 38 (3), pp. 427-432, 2020, ISSN: 0264-410X.

Abstract | Links:

Skowronski DM, Zou M, Sabaiduc S, Murti M, Olsha R, Dickinson JA, Gubbay JB, Croxen MA, Charest H, Jassem A, Krajden M, Bastien N, Li Y, De Serres G

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.

Journal Article

Euro Surveill, 25 (7), 2020, ISSN: 1025-496X.

Abstract | Links:

Lorcy A, Gilca R, Dube E, Rochette M, De Serres G

Feasibility and ethical issues: experiences and concerns of healthcare workers regarding a new RSV prophylaxis programme in Nunavik, Quebec.

Journal Article

Int J Circumpolar Health, 79 (1), pp. 1742564, 2020, ISSN: 1239-9736.

Abstract | Links:

Bettinger JA, De Serres G, Valiquette L, Vanderkooi OG, Kellner JD, Coleman BL, Top KA, Isenor JE, McCarthy AE, Canadian Immunization Research Network

2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.

Journal Article

Euro Surveill, 25 (22), 2020, ISSN: 1025-496X.

Abstract | Links:

Comité sur l'immunisation du Québec, Gilca V, Brousseau N, Sauvageau C, Kiely M, Direction des risques biologiques et de la santé au travail - INSPQ

Reprise des activités de vaccination en milieu scolaire dans le contexte de la COVID-19. Avis du Comité sur l'immunisation du Québec

Book

Institut national de santé publique du Québec, [Montréal, Québec], 2020.

Comité sur l'immunisation du Québec, Brousseau N, Gilca R, Kiely M, De Serres G, De Wals P, Villeneuve J, Direction des risques biologiques et de la santé au travail - INSPQ

Maintien des groupes ciblés dans le cadre du Programme d'immunisation contre l'influenza du Québec dans le contexte de la COVID-19. Avis du Comité sur l'immunisation du Québec

Book

Institut national de santé publique du Québec, [Montréal, Québec], 2020.

Skowronski DM, De Serres G

Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008-2009 Seasonal Influenza Vaccine Receipt.

Journal Article

Clin Infect Dis, 69 (12), pp. 2230-2231, 2019, ISSN: 1058-4838.

| Links:

Skowronski DM, Sabaiduc S, Leir S, Rose C, Zou M, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Bastien N, Li Y, Jassem A, Krajden M, De Serres G

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).

Journal Article

Euro Surveill, 24 (46), 2019, ISSN: 1025-496X.

Abstract | Links:

Skowronski DM, De Serres G, Orenstein WA

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.

Journal Article

Clin Infect Dis, 69 (6), pp. 1084-1085, 2019, ISSN: 1058-4838.

| Links:

339 entries « 2 of 34 »
Signaler des ajouts ou des modifications

Active projects

  • (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • (SI03 QC03) Special Immunization Clinic Network (SIC) to investigate vaccine safety issues: Optimizing the clinical management of patients with contraindication to vaccination ..., Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2019-04-01 to 2022-03-31
  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2021-12-31
  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31

Recently finished projects

  • Capacité du vaccin ... à induire des niveaux protecteurs d'anticorps contre l'influenza B de la lignée Victoria chez des enfants initialement immunisés 9 ans auparavant avec des doses de vaccins contenant la lignée Yamagata (TITER III), Subvention, Ministère de la Santé et des Services sociaux, from 2019-01-15 to 2019-12-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31
Data provided by the Université Laval research projects registery